top of page
Recent Posts

FDA grants orphan drug designation for neuroblastoma vaccine

The U.S. Food and Drug Administration (FDA) granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer.

Search By Tags
bottom of page